Regnante Keith - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 4, 2023, Regnante Keith's relationship to Keros Therapeutics, Inc. (KROS) is Officer (Chief Financial Officer), and currently has 40,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KROS insiders.
Data Source: SEC.
Regnante Keith - Insider Non-Derivative Transactions of KROS Common Stock
Regnante Keith - Insider Non-Derivative Transactions at KROS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 5, 2023 | Sell -- (Common Stock) | 40000 | 45.29 | 0 |
| Nov 5, 2023 | M -- (Common Stock) | 40000 | 16 | 40000 |
| Jun 10, 2023 | Sell -- (Common Stock) | 2579 | 47.25 | 0 |
| Jun 10, 2023 | Sell -- (Common Stock) | 1428 | 46.46 | 2579 |
| Jun 10, 2023 | Sell -- (Common Stock) | 15993 | 45.03 | 4007 |
| Jun 10, 2023 | M -- (Common Stock) | 20000 | 16 | 20000 |
| Jun 9, 2023 | Sell -- (Common Stock) | 2699 | 48.65 | 0 |
| Jun 9, 2023 | Sell -- (Common Stock) | 17301 | 47.66 | 2699 |
| Jun 9, 2023 | M -- (Common Stock) | 20000 | 16 | 20000 |